Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1125 of 1631 entries
View as:

Fosrenol Post-marketing Surveillance for Hemodialysis in Japan

Phase: N/A Priority: Normal
NCT ID: NCT01419327 Org: User:
Start: 03/23/09 End: 05/28/19 Due: 05/28/20

Clinical Study to Evaluate the Maximum Tolerated Dose of BAY1000394 Given in a 3 Days on / 4 Days Off Schedule in Subjects With Advanced Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01188252 Org: User:
Start: 08/31/10 End: 12/31/16 Due: 12/31/17

A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH.

Phase: N/A Priority: Normal
NCT ID: NCT00855465 Org: User:
Start: 02/23/09 End: 06/27/12 Due: 06/27/13

Menorrhagia Study in Women With Treatment-resistant Menorrhagia

Phase: N/A Priority: Normal
NCT ID: NCT00288691 Org: User:
Start: 11/30/01 End: 01/31/04 Due: 01/31/05

Study Evaluating Betaferons Safety and Tolerability In Pediatric Patients With Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT00963833 Org: User:
Start: 12/17/09 End: 09/01/16 Due: 09/01/17

To Evaluate the Bioavailability of a Single Oral Dose of the Acetylsalicylic Acid Containing Dry Powder 500 mg in Comparison to the Bioavailability of a Single Oral Dose of Aspirin Tablets and Aspirin Effervescent Tablets in Healthy Adults.

Phase: N/A Priority: Normal
NCT ID: NCT02394093 Org: User:
Start: 02/28/15 End: 03/31/15 Due: 03/31/16

Study of FVIIa Variant BAY86-6150 (B0189) in Subjects With Moderate or Severe Hemophilia Types A or B With or Without Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT01921855 Org: User:
Start: 01/31/09 End: 12/31/09 Due: 12/31/10

MIRENA for Contraception In InDian Subjects User continuAtion and Satisfaction Study: MIDAS Study

Phase: N/A Priority: Normal
NCT ID: NCT01961375 Org: User:
Start: 10/30/15 End: 09/21/23 Due: 09/21/24

Observational Study on Hypothyroidism in Young Children Following Iodine Contrast Exposure

Phase: N/A Priority: Normal
NCT ID: NCT02766283 Org: User:
Start: 06/30/16 End: 08/30/16 Due: 08/30/17

First Line Treatment of Metastatic Colorectal Cancer With mFOLFOX6 in Combination With Regorafenib

Phase: N/A Priority: Normal
NCT ID: NCT01289821 Org: User:
Start: 02/28/11 End: 06/30/14 Due: 06/30/15

Relative Bioavailability Study

Phase: N/A Priority: Normal
NCT ID: NCT02159313 Org: User:
Start: 06/30/14 End: 01/31/15 Due: 01/31/16

A Study to Learn What Participants Think of Treatment With Betamethasone Plus Loratadine to Treat Their Acute Allergic Rhinitis, Also Known as Hay Fever in Mexico

Phase: N/A Priority: Normal
NCT ID: NCT04645979 Org: User:
Start: 11/11/20 End: 11/27/20 Due: 11/27/21

A Study to Learn More About the Safety and the Blood Level of BAY1747846 Given as Injection Into the Vein at Increasing Single Doses in Chinese Healthy Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT06135181 Org: User:
Start: 08/26/20 End: 04/30/21 Due: 04/30/22

Julina Post-marketing Surveillance for Climacteric Symptoms in Japan

Phase: N/A Priority: Normal
NCT ID: NCT01386281 Org: User:
Start: 10/20/08 End: 04/15/14 Due: 04/15/15

Expanded Access to Provide Larotrectinib for the Treatment of Cancers With a NTRK Gene Fusion

Phase: N/A Priority: Normal
NCT ID: NCT03025360 Org: User:
Start: - End: - Due: -

Dose Escalation of Different Concentrations of ZK 245186 in Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT00944632 Org: User:
Start: 07/15/09 End: 09/15/10 Due: 09/15/11

Thorough ECG (Electrocardiogram) and Drug Interaction Study With Anetumab Ravtansine and Itraconazole

Phase: N/A Priority: Normal
NCT ID: NCT02824042 Org: User:
Start: 09/07/16 End: 08/05/19 Due: 08/05/20

Sinecort Pilot Efficacy Study

Phase: N/A Priority: Normal
NCT ID: NCT00980135 Org: User:
Start: 11/30/09 End: 05/31/10 Due: 05/31/11

Cross-over Study to Prove Bioequivalence Between Two Oral Formulations of Levonorgestrel

Phase: N/A Priority: Normal
NCT ID: NCT01096485 Org: User:
Start: 02/28/09 End: 03/31/09 Due: 03/31/10

Vardenafil ODT (Orally Disintegrating Tablet) - Nifedipine Interaction Study

Phase: N/A Priority: Normal
NCT ID: NCT01348880 Org: User:
Start: 05/31/11 End: 12/31/11 Due: 12/31/12

A Study to Learn More About Treatment With Damoctocog Alfa Pegol, How it is Used in Every Day Practice ("Real-World"), and How Satisfied People Who Receive Damoctocog Alfa Pegol Are in United States (US) Hemophilia Treatment Centers

Phase: N/A Priority: Normal
NCT ID: NCT05395858 Org: User:
Start: 01/17/23 End: 11/06/23 Due: 11/06/24

Study of BAY1834942 in Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03596372 Org: User:
Start: 06/19/18 End: 02/22/21 Due: 02/22/22

Efficacy and Safety Study of an Oral Contraceptive in Healthy Females

Phase: N/A Priority: Normal
NCT ID: NCT00206583 Org: User:
Start: 03/31/05 End: 07/31/07 Due: 07/31/08

Assessment of Efficacy of Vardenafil, Influence on Self-esteem and Self-confidence in Subjects With Erectile Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT00661596 Org: User:
Start: 05/31/03 End: 01/31/04 Due: 01/31/05

Burden of Ischemic Stroke and Intake of Oral Anticoagulants in Patients With Atrial Fibrillation in the UK Primary Care

Phase: N/A Priority: Normal
NCT ID: NCT04099238 Org: User:
Start: 10/01/19 End: 07/16/20 Due: 07/16/21